Endovascular Therapy for Acute PE: SCAI/SIR Update on Ongoing and Completed RCTs

How to Register

To register, press the "Login" or "Register" button.
Sign in with your scai.org username and password. If you don't have an account, click “Set Up Your Login.”
Once registered, you will see a screen where you can add the webinar to your calendar.

If you have already registered, choose "Log In" or "Get Started" to access recorded content.

Webinar Overview

SCAI and SIR are coming together to explore the future of endovascular therapy for acute pulmonary embolism with insights from the PEERLESS trial, the first randomized comparison of catheter-based interventions for intermediate-risk PCI. This event offers expert panel discussion examining the possible implications of this data on clinical practice - as well as questions that are still unanswered - with the goal of helping you stay informed in this evolving field.

Additionally, this expert interdisciplinary panel will discuss other pivotal clinical trials on the horizon that could generate Level 1 evidence, aiming to support your practice with high standards of clinical research. The panel will also answer questions live during this event.

Don’t miss this opportunity to enhance your expertise and elevate patient care. Register now to secure your spot!

December 10, 2024
7-8 pm Eastern Time, 6-7 pm Central Time, 5-6 pm Mountain Time, 4-5 pm Pacific Time.

Faculty and Agenda

Faculty

	Julie Bulman MD, RPVI Panelist		Jay Giri, MD, MPH, FSCAI Key Findings from PEERLESS Trial
	Jun Li MD, FSCAI Panelist		Robert Lookstein, MD, FSIR Moderator
	Eric Secemsky MD, MSc, FSCAI Moderator		Akhilesh Sista, MD, FSIR Panelist

Agenda

Welcome and Overview
Key Findings from the PEERLESS Trial
Panel: How Does PEERLESS Affect Our Practice?
- Key points for interventional cardiologists and radiologists
- What did it answer?
- What questions are still unresolved?
Panel: Current State of Clinical Trails
- HI-PEITHO
- PE-TRACT
- STORM-PE
- PEERLESS II
- PEITHO-3
- PERSERVE
Q&A

Continuing Education Information

Deadline to claim CME credit is December 31, 2024.

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
SCAI designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Attend the live activity in zoom and complete the evaluation to obtain credit.

Learning Objectives

Upon completion of these activities, participants will be able to:

Review data from the PEERLESS trial.

Interpret data and its implications on practice for interventional cardiologists and interventional radiologists.

Discuss other pivotal trials and strategies to generate Level 1 evidence.

Acknowledgment of Commercial Support

This webinar is supported by an unrestricted educational grant from Boston Scientific, Inari Medical, Penumbra.

No in-kind commercial support was received.

Summary


Availability:	No future session
	Access expires on 01/31/2025


Cost:	FREE


Credit Offered:	1 CME Credit 1 ABIM-MOC Point 1 Participation Credit